# Bioventus Inc.: Form 8-K, filed Nov 16, 2022

- Company: [Bioventus Inc.](/companies/bvs.md) (CIK 1665988)
- Form: 8-K
- Filed: 2022-11-16
- Accepted by EDGAR: Nov 16, 2022, 17:21 ET
- Period: 2022-11-16
- Accession: 0001628280-22-030171
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1665988/000162828022030171/bvs-20221116.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1665988/000162828022030171/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1665988/000162828022030171/bvs-20221116.htm

Filed Nov 16, 2022.
Source: SEC EDGAR, the filing index for accession 0001628280-22-030171. Last ingested by Listed: Nov 2, 2026, 17:44 ET. No prices; not investment advice.